This gene test determines a patient’s risk for progression to advanced Age-related Macular Degeneration (AMD) within 2, 5 or 10 years. The test also provides a pharmacogenetic recommendation related to AREDS supplements for AMD.
This genetic test aids in the selection of appropriate oral supplements for AMD based on an individual’s genetic risk profile.
Cytochrome P450 – Personalized Medicine
A new approach to Drug-Based Patient Management
The Cytochrome P450 genetic test covers as many as nine different cytochrome P450 genes. It is designed to identify which prescription medicines and in what doses are right for individual patients. The test provides guidance for the doctor to more than 60 different prescription drugs.
Genetic testing for cystic fibrosis is a Standard of Care in North America. Arctic’s PreCF test provides guidance related to CF carrier screening for pregnant women or those planning a pregnancy. This test meets the recommendations of the American College of Medical Genetics and the American College of Obstetrics and Gynecology for CF Carrier Screening.
Gestational Diabetes Mellitus, GDM
Inherited risk, a family history revealing a first-degree relative with type 2 diabetes, is a risk factor for developing gestational diabetes. There are at least 16 genes where certain mutations are associated with an increased risk of gestational diabetes. The Pre GDM DNA test identifies the inherited risk from these genes.
Corporate Headquarters: ArcticDx Inc.
MaRs Centre, 661 University Ave. Suite 455
Toronto, Ontario M5G 1M1 Canada
T: 1 (866) 964-5182 F: 1 (866) 964-5184
Email: firstname.lastname@example.org or email@example.com
© Arctic Group Of Companies. All Rights Reserved.